Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine
- 1 June 1997
- journal article
- Published by Elsevier in Life Sciences
- Vol. 61 (2) , 153-163
- https://doi.org/10.1016/s0024-3205(97)00370-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- In-vivo microdialysis sampling in pharmacokinetic studiesTrAC Trends in Analytical Chemistry, 1993
- Distribution of Tacrine Across the Blood–Brain Barrier in Awake, Freely Moving Rats Using in Vivo Microdialysis SamplingPharmaceutical Research, 1993
- Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing themdr1 phenotypeCancer Chemotherapy and Pharmacology, 1992
- SDZ PSC 833, A non‐immunosuppressive cyclosporine: Its potency in overcoming P‐glycoprotein‐mediated multidrug resistance of murine leukemiaInternational Journal of Cancer, 1992
- Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumorCancer Chemotherapy and Pharmacology, 1992
- In Vivo Microdialysis Sampling for Pharmacokinetic InvestigationsPharmaceutical Research, 1991
- Microdialysis—Theory and applicationProgress in Neurobiology, 1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Reduced permeability in CHO cells as a mechanism of resistance to colchicineJournal of Cellular Physiology, 1974